Delivery Order SPE2DB22D3016-SPE2DB24FBEF9
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$43K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,534.53 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a $8,582.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a period of performance through April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $14,595.54, is for the delivery of Mavyret 100-40 mg tablets, a specialty medication used to treat hepatitis C. The contract has a period of performance ending on August 9, 2021 and was awarded on a firm fixed-price basis without any set-aside designations. AmerisourceBergen Drug Corp is a subsidiary of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,649.17 Firm Fixed Price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product. The contract has an ultimate completion date of April 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $18,666.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "MAVYRET 100-40 MG TABLET 84S" and has a firm fixed price pricing type with a completion date of March 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) on September 12, 2022. The $80,535.22 firm fixed-price delivery order provides the DLA with Harvoni 90-400 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $41,003.53 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565891282 HARVONI 90-400 MG TABLET UU 28S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $30,107.61 firm-fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. This contract has no set-aside designation and is scheduled for completion by September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $3,643.75 Firm Fixed Price delivery order is for the supply of VEMLIDY 25 MG TABLET in a 30-count package. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,473.77 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets, a medication used in the treatment of Hepatitis B. The contract has an ultimate completion date of May 9, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...